跳至主要内容
临床试验/JPRN-UMIN000007093
JPRN-UMIN000007093招募中未知

Retrospective analysis for the safety of maneuver and the comparison between the image evaluation, the pathological findings, and the final diagnosis, among patients for whom CT-guided biopsy is performed. - Retrospective analysis for the safety and efficacy of CT-guided biopsy

Keio University School of medicine0 个研究点目标入组 1,000 人开始时间: 2012年1月17日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients have no favor to attend this research.

研究者

相似试验

尚未招募
Unknown
A study to evaluate safety and mechanisms through food intake using existing specimens.
JPRN-UMIN000053605Kewpie Corporation
已完成
不适用
An Observational Study of the Safety and Performance of the Vessel Sealing System (LigaSure) in patients with Pulmonary ResectioBenign or malignant pulmonary lesions
JPRN-UMIN000009717Oncological surgery, Hiroshima University Hospital / Department of Thoracic Surgery, Juntendo University Main Hospital200
已完成
不适用
An Observational Study of the Safety and Performance of the Vessel Sealing System (LigaSure) in patients with pulmonary arteries and veins in patients undergoing pulmonary resectioung cancer
JPRN-UMIN000018493Oncological surgery, Hiroshima University Hospital / Department of Thoracic Surgery, Juntendo University Main Hospital200
进行中(未招募)
1 期
Evaluation of the safety and tolerability of re-dosing with intravenous (IV)otelixizumab in adult subjects with newlydiagnosed type 1 diabetes mellitus.Autoimmune new onset type 1 diabetes mellitusMedDRA version: 12.1Level: LLTClassification code 10067584Term: Type 1 diabetes mellitus
EUCTR2010-019157-17-FRGlaxoSmithKline Research and Development LTD
进行中(未招募)
不适用
Evaluation of the safety and tolerability of re-dosing with intravenous (IV)otelixizumab in adult subjects with newlydiagnosed type 1 diabetes mellitus.Autoimmune new onset type 1 diabetes mellitusMedDRA version: 12.1Level: LLTClassification code 10067584Term: Type 1 diabetes mellitus
EUCTR2010-019157-17-DEGlaxoSmithKline Research and Development LTD8